STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma
Status:
Terminated
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
STA9090 is a drug which inactivates or blocks the work of a protein called Heat Shock Protein
90 or HSP90. HSP90 is a protein that helps some molecules inside your cells to have the right
shape. By stopping HSP90's activity, those molecules never get to have the right structure of
be functional and they are destroyed. The investigators believe that if they stop the
activity of HSP90, the rapidly dividing cells that are in your tumor(s) may slow down. In
this research study the investigators are looking to see how well STA9090 works in stopping
the spread of your melanoma.